We also found that membranous PODXL was highly overexpressed in metastatic samples from CRC patients compared to that from non-metastatic samples, and that higher PODXL expression was associated with shorter overall CRC-patient survival based on TCGA data (Figure 3). The gene discussed is PODXL; the disease is colorectal carcinoma.